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Abstract 
Studies on the genetic forms of epilepsy, chronic pain, and migraine caused by mutations in ion 
channels have given crucial insights into the molecular mechanisms, pathogenesis, and therapeutic 
approaches to complex neurological disorders. In this review we focus on the role of mutated Cav2.1 
(i.e., P/Q-type) voltage-activated Ca2+ channels, and on the ultimate consequences that mutations 
causing familial hemiplegic migraine type-1 (FHM1) have in neurotransmitter release. Transgenic 
mice harbouring the human pathogenic FHM1 mutation R192Q or S218L (KI) have been used as 
models to study neurotransmission at several central and peripheral synapses. FHM1 KI mice are a 
powerful tool to explore presynaptic regulation associated with expression of Cav2.1 channels. 
Mutated CaV2.1 channels activate at more hyperpolarizing potentials and lead to a gain-of-function in 
synaptic transmission. This gain-of-function might underlie alterations in the excitatory/ inhibitory 
balance of synaptic transmission, favoring a persistent state of hyperexcitability in cortical neurons that 
would increase the susceptibility for cortical spreading depression (CSD), a mechanism believed to 
initiate the attacks of migraine with aura.  
 
Keywords: Cav2.1 (P/Q-type) Ca2+ channels, familial hemiplegic migraine, cortical spreading 
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Migraine and Familial Hemiplegic Migraine (FHM) 
 
Migraine is a common, chronic neurovascular disorder, typically characterized by recurrent attacks (1-
3 days) of disabling headaches with associated autonomic symptoms. Twelve percent of the general 
population has on average one to two migraine attacks per month and treatments are frequently 
unsatisfactory. The etiology of migraine is multifactorial (for reviews, see Marmura and Silberstein 
2011, Goadsby et al. 2002 and Pietrobon and Striessnig 2003). The migraine pain is likely to be 
triggered by activation of the trigeminovascular system, which primarily modulate sensory signal 
transmission trough the activation of trigeminal afferents to meningeal blood vessels, the trigeminal 
nerve, and brainstem nuclei.  
In 20% of cases, the migraine headache is preceded by a visual hallucination/illusion known as aura. 
There is growing evidence from animal models suggesting that CSD is the electrophysiological event 
underlying migraine aura (Haerter et al. 2005, Lauritzen 1994). In experimental animals, CSD is an 
intense and steady depolarization of neuronal and glial cell membranes that last for less than one 
minute, which can spread to contiguous cortical areas of the brain at a rate of 3 to 5 mm/min, 
regardless of functional cortical divisions or arterial territories. Evoked when local extracellular K+ 
concentrations exceed a critical threshold, CSD is associated with disruption of membrane ionic 
gradients, massive influxes of Ca2+ and Na+, and massive K+ efflux with concomitant glutamate 
release. All such ionic unbalance is believed to depolarize adjacent neurons and glia, thereby 
facilitating its spread. An advancing wave of brief excitation would then be followed by a longer-
lasting inhibition of spontaneous and evoked neuronal activity that traverses the cortex (Somjen 2001, 
Goadsby 2007, Pietrobon 2005, Lauritzen 1994, Cutrer et al. 1998, Hadjikhani et al. 2001 and Bowyer 
et al. 2001). In humans, evidence for a causal role of CSD in the aura comes from functional magnetic 
resonance imaging (fMRI) performed during migraine attacks with aura (Hadjikhani et al 2001) 
The nature and mechanisms of the primary brain dysfunction leading to the activation of the meningeal 
trigeminal nociceptors remain incompletely understood (for reviews see Charles 2009, Goadsby et al 
2009a, Levy et al 2009) and it is controversial whether CSD can initiate the migraine headache 
cascade by itself. Animal studies support the idea that CSD may also initiate the headache 
mechanisms, but the connection between CSD and headache in patients (particularly those with 
migraine without aura) remains an open question (Ayata 2009, Pietrobon and Striessnig 2003). On the 
other hand, there is experimental animal evidence that CSD might activate the trigeminal sensory 
system, presumably by depolarizing perivascular trigeminal terminals at meningeal and dural blood 
vessels (Haerter et al. 2005, Ayata et al. 2006, Bolay et al. 2002).  Zhang et al (2010, 2011) 
demonstrated, for the first time, that the induction of CSD by focal stimulation in vivo of the rat visual 
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cortex can lead to long-lasting activation of the nociceptors innervating the meninges in the trigeminal 
ganglion.  
Current views of migraine describe it primarily as a multi--factorial brain disorder with an estimated heritability 
as high as 50% (Mulder et al. 2003). Genetic research in the field of migraines has mainly focused on the 
identification of genes involved in familial hemiplegic migraine (FHM), a rare monogenic subtype of migraines 
with aura. Genes for three monogenic subtypes of migraine have been identified  so far (van den Maagdenberg 
et al 2007): CACNA1A (FHM1, encoding the pore-forming  1 subunit of CaV2.1 calcium channels; Ophoff et al. 
1996), ATP1A2 (FHM2, encoding the  2-subunit of sodium-potassium (Na+, K+) pumps present in glial cell; De 
Fusco et al. 2003), and SCN1A (FHM3, encoding the pore-forming  1-subunit of neuronal NaV1.1 voltage gated 
sodium channels, Dichgans et al. 2005).  
More recently, in some patients suffering from migraine an homozygous mutation in the SLC4A4 gene 
(NBCe1, encoding the electrogenic Na(+)-HCO(3)(-) co-transporter was found; Suzuki et al. 2010). The 
immunohistological and functional analyses of these mutants demonstrate that the nearly total loss of NBCe1 
activity in astrocytes can cause migraine potentially through dysregulation of synaptic pH.  
A link between  a common form of migraine and a genetic mutation of the TWIK-related spinal cord (TRESK) 
two-pore domain potassium channel (K2P), encoded by KCNK18, was recently reported (Lafreniere et al 2010). 
By screening the KCNK18 gene in a large multigenerational family with typical migraine with aura, inherited in 
a dominant fashion, Lafreniere et al (2010) identified a mutation in TRESK (F139WfsX24). They also identified 
prominent TRESK expression in migraine salient areas such as the trigeminal ganglion. The F139WfsX24 
mutation produces a frame shift that prematurely truncates the channel in the second transmembrane domain 
and causes a complete loss of TRESK function. In addition, the mutant subunit suppresses wild-type channel 
function through a dominant negative effect, thus, explaining the dominant penetrance of this allele. It is 
expected that the TRESK mutation would make the trigeminal neurons more easily excitable. Increasing 
TRESK activity might help to diminish the excitability of these neurons, and may lessen migraine severity or 
incidence, whereas decreasing activity (through KCNK18 mutations) may increase the risk of migraine. 
A recent genome-wide association study in a large clinic-based sample of European individuals with migraine 
identified a genetic variant on chromosome 8q22.1 associated with migraine (Anttila et al 2011). Furthermore, 
in a new study including 5,122 migraineurs and 18,108 non-migraineurs, several single nucleotide 
polymorphism associations (SPNs) specific for migraine were identified (Chasman et al 2011) establishing a 
link of migraine with LRP1 (modulator of glutamate signaling) and TRPM8 receptors (related to neuropathic 
pain models).  
a.        FHM type 2: Glial cells have a central role in migraine 
 Mutations in the ATP1A2 gene are responsible for at least 20 percent of FHM cases. The FHM2 
ATP1A2 gene encodes the α2 subunit of a Na+,K+ pump ATPase (De Fusco et al. 2003, Marconi et al. 
2003). This catalytic subunit binds Na+, K+, and ATP, and utilizes ATP hydrolysis to extrude Na+ ions 
out of the cell while moving K+ ions in. Na+ pumping provides the steep Na+ gradient essential for the 
transport of glutamate and Ca2+. The gene is predominantly expressed in neurons at the neonatal stage 
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and in glial cells at the adult (De Fusco et al. 2003, Vanmolkot et al. 2003). An important function of 
this specific ATPase in adults is to modulate the key reuptake of potassium and glutamate from the 
synaptic cleft into the glia (Moskowitz et al 2004). When this mechanism fails, it leads to elevated 
extracellular levels of glutamate and potassium, and accordingly, to an increased susceptibility to CSD 
(Pietrobon 2007, Koenderink et al 2005). All FHM2 mutations studied in heterologous expression 
systems result in a “loss-of-function” or a kinetically altered Na+, K+ pump (Pietrobon 2007, Tavraz  et 
al 2008, Vanmolkot et al. 2006, De Fusco et al. 2003, Segall et al. 2005).  
Leo et al (2011) have reported the generation of the first mouse model of FHM2, a knock-in mutant 
harboring the human W887R-ATP1A2 mutation which decreases induction threshold and increases the 
velocity of propagation of CSD. The authors suggested a relatively minor role of the glial  2 Na,K 
pump in K+ clearance meaning that the reduced CSD threshold in FHM2 knockin mice would not be 
primarily due to impaired K+ reuptake. Instead their evidence point to an inefficient astrocyte clearance 
of glutamate and a consequent increased cortical excitatory neurotransmission.   
b.  FHM type 3: Sodium channels and migraine 
FHM type 3 is caused by missense mutations in SCN1A, the genes encoding the pore-forming subunits 
of the neuronal voltage-gated Na+ channel NaV1.1 (Dichgans et al. 2005). 
Kahlig et al (2008) investigated the functional consequences of two mutations linked to FHM3: 
Q1489K and L263V.  Q1489K mutation, when compared to WT-NaV1.1, causes a predominantly loss-
of-function phenotype, as deduced from a more rapid onset of slow inactivation, delayed recovery 
from fast and slow inactivation and a greater loss of channel availability during repetitive stimulation. 
However, opposite effects of the same mutation on tsA-201 cells and rat cultured neurons transfected 
with human Nav1.1 were observed by Cestele et al (2008). L263V exhibited biophysical abnormalities 
compatible with a gain-of-function mutation: increased persistent (not inactivating) current, delayed 
entry into fast and slow inactivation, depolarizing shifts in the steady-state voltage dependence of both 
fast and slow inactivation, accelerated recovery from fast inactivation, and greater channel availability 
during repetitive stimulation Kahlig et al (2008). Notably, greater channel availability during repetitive 
stimulation, as seen for L263V mutation, has also been observed for various epilepsy-associated 
SCN1A mutations (Rhodes et al 2005) and might correlate with the unusually high prevalence of 
epilepsy observed in L263V mutation carriers. The coincidence of migraine with epilepsy suggests that 
these two neurological disorders may share common mechanisms in L263V mutation carriers.  
Nav1.1 is the major target for epileptogenic mutations and different mutations in this gene are known 
to be associated with epilepsy and febrile seizures (Meisler and Kearney 2005, Avanzini et al. 2007). 
However, interestingly, just few cases of seizures have been reported in FHM patients (Dichgans et al. 
2005, Vanmolkot et al. 2007). Thus, FHM mutations could be modifying Nav1.1 differently compared 
to purely epileptogenic mutations.  
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Studies using heterologous expression and functional analysis of recombinant Nav1.1 channels suggest 
that epilepsy mutations in Nav1.1 may cause either gain-of-function or loss-of-function effects that are 
consistent with either increased or decreased neuronal excitability (Ragsdale 2008, Cestele et al 2008). 
However, most Nav1.1 mutations have their ultimate epileptogenic effects by reducing Nav1.1-
mediated whole cell sodium currents in GABAergic neurons, resulting in widespread loss of brain 
inhibition, an ideal background for the genesis of epileptic seizures (for review: Catterall et al 2010, 
Ragsdale 2008).  
GABAergic interneurons are particularly sensitive to the loss of Nav1.1 in gene-targeted mice (Yu et 
al. 2006, Ogiwara et al. 2007), probably because Nav1.1 is expressed at higher levels in GABAergic 
interneurons than in glutamatergic pyramidal neurons. Hence, epileptogenic mutations may cause 
seizures because of decreased inhibition in neuronal circuits. 
Because NaV1.1 channels are crucial for the generation and propagation of action potentials, the 
overall effects of FHM3 mutations are most likely an increased frequency of neuronal firing plus an 
enhanced neuronal excitability and neurotransmitter release.  
c.  FHM type 1: A central role of voltage activated calcium channels in migraine 
Voltage-gated calcium channels can be classified based on their biophysical characteristics, into high-
voltage-activated (HVA) and low-voltage-activated (LVA) channels. LVA Ca2+ channels encompass 
the family of T-type channels with three members (Cav3.1 through Cav3.3). They activate at a 
relatively negative threshold of around –60 mV, have a small conductance, and inactivate rapidly. 
They are inhibited by drugs like mibefradil (Ro 40-5967) or 2-octanol (Llinas 1988; Perez-Reyes 
2003; Urbano et al., 2009; Bisagno et al., 2010). HVA Ca2+ channels include seven members (CaV1.1 
to 1.4, CaV2.1 to 2.3) encoded by distinct genes each with multiple splice variants (Catteral 2000). 
HVA channels typically have an activation threshold of around –30 mV, with the exception of CaV1.3, 
which activates at around -50 mV (Xu and Lipscombe 2001). CaV1.1 to 1.4 channels, also referred to 
as L-type channels, are inhibited by three classes of drugs, dihydropyridines, phenylalkylamines, and 
benzothiazepines (Striessnig et al. 1998). Selective inhibitors for specific channels have also been 
described: CaV2.1 (P/Q-type) channels are selectively blocked by  -agatoxin IVA (Mintz et al. 1992), 
while CaV2.2 (N-type) channels are inhibited by  -conotoxin GVIA (Plummer et al. 1989, Aosaki and 
Kasai 1989) and CaV2.3 (R-type) channels are blocked by SNX-482 (Newcomb et al. 1998, Tottene et 
al. 2000). 
HVA Ca2+ channels are heteromultimers of a pore forming α1 subunit that co-assembles with ancillary 
β, α2δ (and in some cases a γ subunit) into a functional channel complex (Baumgart and Perez-Reyes 
2009, Catterall et al 2005). In contrast, LVA Ca2+ channels are α1 subunit monomers. The α1 subunit 
defines the channel subtype, whereas the ancillary subunits modulate α1 subunit function and surface 
expression. Vertebrates express four different types of calcium channel β subunits (β1 through β4), 
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four different types of α2δ subunits (α2δ1 through α2δ4), and as many as eight different γ subunits 
(Baumgart and Perez-Reyes 2009, Black 2003). 
P/Q-type, N-type and, to some extent, R-type channels are highly expressed at presynaptic nerve 
terminals where their activities evoke neurotransmitter release (Katz et al. 1996, Iwasaki et al. 2000, 
Nudler et al. 2003, Trimmer and Rhodes 2004).   
c.1. Cav2.1 (P/Q-type) calcium channels 
Cav2.1 channel contains a pore-forming α1A subunit and several regulatory subunits, including 
intracellular β subunits (Cavβ1–4) that bind to the intracellular loop between transmembrane domains I 
and II of α1A. The effect of the regulatory subunits is essential for increasing the expression levels and 
modulating the voltage-dependent activation and inactivation of Cav2.1 channels (Baumgart and 
Perez-Reyes 2009, Birnbaumer et al 1998Catterall 2000, Di Guilmi et al., 2011, Jones 2002, Stotz et al 
2004, Uchitel et al., 2010) as well as targeting the channels to the plasma membrane. Cav2.1 channels 
are located throughout the mammalian brain and spinal cord (Westenbroek et al. 1995) at presynaptic 
terminals (Catterall 1998, Wu et al. 1999, Mintz et al. 1995) and at somatodendritic membranes. The 
CACNA1A gene encoding Cav2.1 channels undergoes alternative splicing at multiple loci in an age-, 
gender-, and species-dependent manner (Bourinet et al 1999, Chang et al 2007, Chaudhuri et al 2005, 
Kanumilli et al 2006, Soong et al 2002). This mechanism resultes in multiple Cav2.1 splice variants 
with different outcomes in neuronal distribution and subcellular localization, biophysical properties, 
and sensitivity to ω-AgaIVA. Further functional diversity of CaV2.1 channels is generated by the 
combination of Cav2.1 α1 subunits with various auxiliary β and α2δ subunits (Luvisetto et al 2004). 
Indeed, evidence exists for large functional and pharmacological diversity of native Cav2.1 channels 
(Mermelstein et al 1999, Mintz et al 1992, Randall and Tsien 1995, Tottene et al 1996, Tringham et al 
2007, Usowicz et al 1992). They play a prominent role in initiating action-potential-evoked 
neurotransmitter release both at peripheral neuromuscular junctions and central synapses, mainly 
within the cerebellum, brainstem, and cerebral cortex (Katz et al. 1996, Catterall 1998, Iwasaki et al. 
2000). Even when pharmacological and electrophysiological studies in brain slices from rodents have 
revealed that P/Q-, N- and R-type channels cooperate in controlling release at many central excitatory 
synapses, P/Q-type channels have a dominant role, partly because of their more efficient coupling to 
the exocytotic machinery (González Inchauspe et al. 2004, Li et al 2007, Matsushita et al. 2002, Qian 
and Noebels 2001, 2000, Wu et al 1999, Mintz et al. 1995). 
At many central synapses, including the inhibitory synapses between Purkinje cells and deep cerebellar 
nuclei neurons, there is a developmental change in the Ca2+ channel types mediating synaptic 
transmission, whereby the relative contribution of Cav2.1 channels increases with post-natal age, until 
it becomes exclusively dependent on P/Q-type channels (Iwasaki et al 2000). At certain synapses, N- 
or R-type Ca2+ channels fail to fully compensate the lack of Cav2.1 channels in Cav2.1-/- and other 
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loss-of-function Cav2.1 mouse mutants (González Inchauspe et al 2004, 2007, Giugovaz et al 2011, 
Pietrobon 2005). Among the presynaptic Ca2+ channels, Cav2.1 channels are also unique in their 
capacity for interacting and being modulated in a complex manner by a number of Ca2+-binding 
proteins (Catterall and Few 2008). As a result, Cav2.1 channels may exhibit either Ca2+-dependent 
inactivation (CDI) or Ca2+-dependent facilitation (CDF). Moreover, Ca2+-dependent regulation of 
presynaptic Cav2.1 channels may play a crucial role in short-term synaptic plasticity during trains of 
action potentials (Adams et al 2010, González Inchauspe et al 2004, Mochida et al 2008, Muller et al. 
2008, Takago et al. 2005, Xu and Wu 2005, González Inchauspe et al 2004, Tsujimoto et al 2002, 
Cuttle et al 1998, Takahashi et al. 1996).  
Cav2.1 channels are expressed in those brain structures implicated in the pathogenesis of migraine, 
including the cerebral cortex, the trigeminal ganglia, and brainstem nuclei involved in the central 
control of nociception, their expression being particularly high in the cerebellum (Pietrobon and 
Striessnig 2003). In the cerebral cortex, excitatory synaptic transmission at pyramidal cell synapses in 
different cortical areas depends predominantly on Cav2.1 channels (Ali and Nelson 2006, Iwasaki et al 
2000, Koester and Sakmann 2000, Rozov et al 2001, Tottene et al 2009, Zaitsev et al 2007). They also 
mediate about 40% of the AP-evoked Ca2+ influx in dendritic spines and shaft of layer 2/3 cortical 
pyramidal neurons (Koester and Sakmann 2000) and contribute to the regulation of the intrinsic firing 
of the same neurons via activation of different Ca2+-dependent K+ (KCa) channels (Pineda et al 1998). 
However, it is still a central problem in Ca2+ channel neurobiology studies to be able to translate their 
genetic complexity to their functional role in synaptic transmission. The availability of several mouse 
models with mutations in Ca2+ channel genes have provided a valuable tool to define Ca2+ channel 
functions. It would be expected that changes in the functional properties of Cav2.1 channels alter the 
behavior of neuronal networks.  
c.2. Familial Hemiplegic Migraine type 1. 
  FHM1 is an autosomal-dominant subtype of migraine with aura, caused by a spontaneous 
missense mutation in the CACNA1A gene encoding the ion-conducting, pore-forming α1A subunit of 
Cav2.1 channels (Pietrobon 2005, Ophoff et al. 1996). FHM1 missense mutations reported so far 
produce substitutions of conserved amino acids in important functional regions of the Cav2.1 channel 
including the pore lining and the voltage sensors (Cuenca-Leon et al 2008, Pietrobon 2007, Thomsen 
et al 2007) and have been associated with a wide range of clinical phenotypes (Haan et al. 2005, Kors 
et al. 2004, Alonso et al. 2004). Aside from the characteristic transient hemiparesis, typical attacks of 
FHM1 are identical to those of the common forms of migraine with aura (Pietrobon and Striessnig 
2003, Pietrobon 2005, Thomsen et al. 2002). Different clinical phenotypes include pure types of 
FHM1 (Ophoff et al. 1996), combinations of FHM1 with various degrees of cerebellar ataxia (Ducros 
et al. 2001, Ophoff et al. 1996), or fatal coma due to excessive cerebral edema (Kors et al. 2001, 2002).  
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Disorders not associated with FHM are episodic ataxia type 2 (Zafeiriou  et al 2009, Cuenca-Leon et al 
2009, Cricchi et al 2007, Jen et al. 2004, 2007, 2008, Ophoff et al. 1996), progressive ataxia (Yue et al. 
1997), spinocerebellar ataxia type 6 (Tsou et al 2011, Restituito et al 2000, Ishikawa et al 1999, 
Zhuchenko et al. 1997) and absence (Imbrici et al. 2004) and generalized epilepsy (Haan et al. 2005, 
Jouvenceau et al. 2001). In addition FHM1 mutations were also found in family members who had 
only “normal” no-paretic migraine but no FHM. This suggests that gene mutations for FHM may also 
be responsible for the common forms of migraine, probably due to different genetic and no-genetic 
modulating factors. Hence, FHM is considered a valid monogenic model for studying the pathogenetic 
mechanisms involved in the genetically more complex common forms of migraine (Ferrari et. al. 
2008, Ducros et al 2001). 
c.3. Functional consequences of FHM1 gene mutations: Studies in heterologous systems 
Biophysical analysis of FHM1 Ca2+ channel dysfunction in heterologus systems show that the 
FHM1 mutations alter many biophysical properties of human Cav2.1 channels in a complex way, 
which is rather debateable since both loss-of-function and gain-of-function phenotypes have been 
reported (Cao et al. 2004, Barrett et al. 2005, Cao and Tsien 2005, Tottene et al. 2002, Kraus et al. 
2000, 1998, Hans et al. 1999). The most consistent effect revealed by the analysis of single-channel 
properties of human CaV2.1 channels carrying FHM1 mutations was an increase in channel open 
probability and in single channel Ca2+ influx over a broad voltage range, mainly due to a shift of 
channel activation to more negative voltages (Tottene et al. 2002, 2005, Hans et al. 1999). Shifts to 
lower voltages of activation of the mutant channels were also revealed by measuring whole-cell 
currents in heterologous expression systems and transfected neurons (Adams et al 2009, Melliti et al 
2003, Mullner et al 2004, Serra et al 2009, Tottene et al 2002, 2005, Weiss et al 2008). As a result, 
channels open with smaller depolarizations. However, the overall change in calcium influx at 
presynaptic terminals is difficult to predict since there have been contradictory results. For instance, 
Cao and colleagues (2004) found evidence for reduced calcium influx at the whole cell level in 
transfections of cultured mouse hippocampal neurons. What happens in the mutant brain will therefore 
be determined by the delicate interplay between the functional effects of a particular mutation, the 
different channel properties and density, the type of channel subunits, and the direct and indirect 
cellular environment. Since the biophysical effects of FHM1 mutations can be affected by a number of 
factors, including Cav2.1 splice-variation (Adams et al 2009), β subunit coexpression (Mullner et al. 
2004), and the nature of the expression system (Kraus et al 1998), it seems pertinent to study the 
functional consequences of gene mutations on P/Q-type Ca2+ and synaptic transmission in their native 
neuronal environment and at their endogenous level of expression in knock-in mouse models carrying 
human pathogenic mutations. 
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c.4. Functional consequences of FHM1 gene mutations: Studies in mice models including 
FHM1 CACNA1A Knock-in mutations 
The generation of two knock-in FHM1 mouse models carrying either the human pathogenic 
R192Q or S218L missense mutations allowed the first analysis of the functional consequences of 
FHM1 mutations on Cav2.1 channels and synaptic transmission in neurons expressing the channels at 
the endogenous physiological level (Maagdenberg et al 2010, 2004, Kaja et al. 2010, Tottene et al 
2009, González Inchauspe et al 2010, Adams et al 2010). 
The R192Q KI mice exhibit no overt clinical phenotype or structural abnormalities. This situation is 
very similar in  humans, where the R192Q mutation causes only mild FHM attacks, very similar to the 
common forms of migraine, albeit with hemiparesis, but without any other neurological symptoms. 
The S218L mutation causes a severe migraine phenotype combined with slowly progressive cerebellar 
ataxia and atrophy, epileptic seizures, coma or profound stupor, and severe, sometimes fatal, cerebral 
edema which can be triggered by a trivial head trauma (Chan et al 2008, Kors et al 2001, van den 
Maagdenberg et al 2010). 
As noted before, CSD is implicated in the pathophysiology of FHM1. In both R192Q and S218L KI 
mice, a lower threshold for CSD induction and an increased velocity of CSD propagation was reported 
(van denMaagdenberg et al. 2004, 2010, Tottene et al. 2009, Eikermann-Haerter et al. 2009 a). In 
agreement with the higher incidence of migraine in females, the velocity of propagation and the 
frequency of CSDs were larger in females than in males of both mutant strains (Eikermann-Haerter et 
al. 2009 a,b). The sex difference was abrogated by ovariectomy and enhanced by orchiectomy, 
suggesting that female and male gonadal hormones exert reciprocal effects on CSD susceptibility. A 
female predominance is also described for familial (5:2 ratio) and sporadic (4.25:1 ratio) hemiplegic 
migraine (Eriksen et al 2006, Thomsen et al 2007, 2002). All these findings underscore the complex 
synergistic interactions between genetic and hormonal factors determining migraine susceptibility. 
Accordingly to the larger gain-of-function observed in vitro, the S218L KI mice shows higher CSD 
susceptibility, in vivo, compared to the R192Q mice. Experimentally induced CSD induces pure 
hemiplegia in R192Q mutant mice, whereas S218L mutants additionally develop coma and often fatal 
seizures (van den Maagdenberg et al. 2010, Eikermann-Haerter et al. 2009 Recently, Eikermann-
Haerter et al (2011) have provided evidence for an enhanced subcortical SD susceptibility in both 
FHM1 mutant mice compared to WT. Whereas the facilitated subcortical spread appeared limited to 
the striatum in R192Q mutants, hippocampal and thalamic spread was detected in the S218L mutants 
with an allele-dosage effect. Their findings suggest a role for subcortical SD as a potential mechanism 
to explain hemiplegia, seizures, and coma in FHM1.  
Other studies in knock in animals revealed multiple gain-of-function effects. In cerebellar granule cells 
and cortical pyramidal cells of R192Q and S218L KI mice, the Cav2.1 Ca2+ current density was larger 
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than in WT neurons in a wide range of relatively mild depolarizations, reflecting activation of mutant 
mouse Cav2.1 channels at 8–9 mV more negative voltages than the corresponding WT channels. P/Q 
current densities were similar in KI and WT neurons at higher voltages (that elicit maximal Cav2.1 
channel open probability), indicating similar densities of functional Cav2.1 channels (van den 
Maagdenberg et al 2004, 2010, Tottene et al 2009). Thus, in two different FHM1 mouse models and 
two different types of neurons the functional consequences of the FHM1 mutations on native neuronal 
mouse Cav2.1 channels were quite similar to those on single recombinant human Cav2.1 channels 
(Tottene et al 2002, 2005). In agreement with the lower threshold of activation of human S218L 
Cav2.1 channels compared to that of human R192Q CaV2.1 channels (Tottene et al 2005), the gain of 
function of the P/Q current at low voltages was larger in S218L than R192Q KI mice (van den 
Maagdenberg et al 2004, 2010). Similarly, a negative shift in the activation voltage of presynaptic 
Cav2.1 mutated channels was confirmed at the calyx of Held synapse of KI S218L mice (Di Guilmi et 
al, unpublished results). 
The first indication that the gain of function of Cav2.1 channels produced by FHM1 mutations could 
lead to enhanced evoked neurotransmitter release was obtained at the neuromuscular junction (NMJ), 
where evoked neurotransmission was unaltered at physiological Ca2+ ion concentrations but increased 
at 0.2 mM Ca2+ in KI mice (Kaja et al 2005, van den Maagdenberg et al 2004, 2010). Recently, 
cortical excitatory neurotransmission was investigated in neuronal microcultures and in brain slices 
from homozygous R192Q KI mice (Tottene et al 2009). The results show increased synaptic strength 
at physiological Ca2+ concentration, presumably, due to enhanced action potential-evoked Ca2+ influx 
through mutant Cav2.1 channels and enhanced probability of glutamate release at cortical pyramidal 
cell (PC) synapses. Short-term synaptic depression during trains of action potentials was enhanced. 
Neither amplitude nor frequency of miniature postsynaptic currents were altered, indicating the 
absence of homeostatic compensatory mechanisms at excitatory synapses onto pyramidal cells 
(Tottene et al 2009).  
Characteristically, CSD arises spontaneously in response to specific triggers that somehow create in 
the cortex of migraineurs the conditions for initiating the positive feedback cycle that overwhelms the 
regulatory mechanisms controlling cortical [K+]o and ignites CSD. Insights into how this might occur 
have been provided by the interesting finding that, in contrast with the enhanced glutamatergic 
excitatory neurotransmission at PC synapses, inhibitory GABAergic neurotransmission at fast spiking 
(FS) interneurons was not altered in R192Q KI mice, despite being mediated by Cav2.1 channels 
(Tottene et al 2009). Given the evidence that the magnitude (or even the presence) of the negative shift 
in activation of human Cav2.1 channels produced by FHM1 mutations may depend on the particular 
recombinant Cav2.1 α1 splice variant and/or Cav2.1 β subunit (Mullner et al. 2004, Adams et al. 
2009), a possible explanation for the unaltered inhibitory transmission at the FS interneurons may be 
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the presence of a Cav2.1 isoform that is little affected by the mutation or a near saturation of the 
presynaptic Ca2+ sensors. Evoked transmitter release was also found to be normal at the neuromuscular 
junction and at the calyx of Held synapse of R192Q KI mice when studied in normal Ca/Mg 
concentration in the external solution (González Inchauspe et al 2010). This finding was unexpected 
since mutated R192Q Cav2.1 channels at the calyx of Held nerve terminals are active at lower 
membrane potentials as predicted. Interestingly, transmitter release at the FS interneurons, at the 
neuromuscular junction and at the calyx of Held is triggered by a relatively brief action potential. In 
each of these R192Q KI preparations transmitter release is not affected. Thus, one factor that may be 
controlling the expression of a synaptic gain of function in the FHM1 KI mice is the duration of the 
action potential (AP) triggering transmitter release. To address this question we used the calyx of Held, 
a giant glutamatergic synapse in the mammalian auditory brainstem where, due to its size and 
accessibility, it is possible to make direct patch-clamp recordings from the presynaptic nerve terminal 
and its postsynaptic target, the principal neurons of the medial nucleus of the trapezoid body (MNTB). 
The large size of the calyx of Held allows it to harbor hundreds of active zones and thus a single 
presynaptic AP releases hundreds of quanta, generating a large excitatory postsynaptic current (EPSC) 
that rapidly depolarizes the MNTB neuron to threshold. A single MNTB principal neuron receives 
input from only one calyx of Held presynaptic terminal, and glutamatergic synaptic transmission 
mediated by AMPA receptors is triggered almost exclusively by Cav2.1 channels in mature mice (for a 
review,  Schneggenburger and Forsythe 2006). The presynaptic Ca2+ currents (IpCa) from the calyx of 
Held terminals recorded in brainstem slices also activate at more hyperpolarizing potentials in R192Q 
KI than in WT mice (González Inchauspe et al 2010). Assuming presynaptic Ca2+ currents through 
Cav2.1 channels can be modeled by Hodgkin–Huxley equations, a shift to more negative activation 
voltages by the FHM1 mutation theoretically should generate larger Ca2+ currents during APs (Borst 
and Sakmann 1999). However, the short duration of the calyx of Held APs (half-width: 0.45 ± 0.02 
ms) elicited IpCa with similar amplitudes in both WT and R192Q KI mice. Only when the AP duration 
was prolonged to 2 ms (typical mean half-width of pyramidal neuron APs), the shift in the activation 
by the R192Q mutation was sufficient to cause greater presynaptic Ca2+ influx (González Inchauspe et 
al 2010). According to the similarity in IpCa amplitudes evoked by physiological calyx of Held APs, 
there were no differences in mean amplitudes of EPSCs between WT and R192Q KI mice. However, 
when synaptic transmission was triggered by long duration APs (obtained by inhibiting K+ channels 
with 4-Aminopyridine and tetraethylammonium chloride), FHM1 R192Q KI mice did show a 
significant increase in both amplitude and area of EPSCs compared to WT mice (González Inchauspe 
et al., unpublished results). Thus, the expression of FHM1 mutations might vary according to the shape 
of the APs in charge of triggering synaptic transmission, adding to the complexity of the 
pathophysiology of migraine.  
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c.5. Effects of FHM1 mutation on synaptic plasticity 
The dynamics and strength of neural circuits are essential for encoding and processing 
information in the CNS and rely on short and long forms of synaptic plasticity. In several synapses, 
repetitive stimulation causes short term depression (STD). Short-term depression of synaptic release 
has been traditionally accredited to depletion of the release-ready vesicle pool (von Gersdorff and 
Borst 2002, Wong et al. 2003, Zucker and Regehr 2002, Wang and Kaczmarek 1998), although other 
mechanisms like receptor desensitization (Wong et al. 2003) may be involved. At the large calyx of 
Held synapse, it has been shown that short-term synaptic plasticity is also achieved by a mechanism 
involving the regulation of presynaptic Cav2.1 Ca2+ currents (Cuttle et al 1998, Tsujimoto et al 2002), 
like calcium channel inactivation (Xu and Wu 2005, Muller et al 2008, Forsythe et al. 1998, Di Guilmi 
et al. 2011) and calcium channel inhibition by presynaptic metabotropic glutamate receptor (von 
Gersdorff et al. 1997, Takahashi et al. 1996) or AMPA receptors (Takago et al. 2005). Hennig et al. 
(2008) have developed a model of synaptic depression at the calyx of Held synaptic terminal that 
combines many of the mechanisms involved in short term depression and plasticity, including vesicle 
recycling, facilitation, activity-dependent vesicle retrieval and multiple mechanisms affecting calcium 
channel activity and release probability. The efficacy of synaptic transmission during repetitive 
stimulation is also determined by the rate of recovery from STD, owed to the replenishment of the 
readily releasable pool of synaptic vesicles, which is dynamically regulated by Ca2+ influx through 
voltage-gated Ca2+ channels in an activity dependent manner (Zucker and Regehr 2002, Wang and 
Kaczmarek 1998). High-frequency stimulation of presynaptic terminals significantly enhances the rate 
of replenishment. Therefore, mutations or neuromodulators capable of altering the 
activation/inactivation properties of calcium channels (Di Guilmi et al. 2011; Uchitel et al. 2010) may 
also alter STD and/or vesicle replenishment. Recordings in connected MNTB neurons at the calyx of 
Held synapses show that EPSC amplitudes depress to the same extent and with similar kinetics in WT 
and R192Q KI mice, but, interestingly, the rate of recovery of EPSCs amplitudes was significantly 
faster in R192Q KI compared to WT synapses (González Inchauspe et al., unpublished results).  
Ca2+-dependent facilitation (CDF) of Cav2.1 channels is an important mechanism required for normal 
synaptic plasticity at fast synapses in the mammalian CNS. As an example, at the calyx of Held 
synapse of Cav2.1 KO mice, lack of pair pulse facilitation of presynaptic Ca2+ channels was in 
correlation with absence of facilitation of synaptic transmission (González Inchauspe et al 2004, 
2007). In the same animal model, pair pulse facilitation of end plate potential was also impaired in the 
neuromuscular junction (Urbano et al 2003). Short-term facilitation of synaptic release has been 
attributed to enhanced vesicle release resulting from the accumulation of intracellular Ca2+ in 
presynaptic terminals during repetitive action potentials (APs), where the buildup of residual Ca2+ 
enhances binding to those sensor proteins directly mediating vesicle fusion and transmitter release 
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(Atluri et al 1996, Zucker and Regehr 2002). There may exists at least another mechanism of 
facilitation, driven by a Ca2+ sensor with high Ca2+ affinity that can detect modest, transient levels of 
Ca2+, most likely near the pore of presynaptic Ca2+ channels (Atluri et al 1996). A recent study using 
recombinant Cav2.1 channels expressed in cultured superior cervical ganglion neurons demonstrated 
that the Ca2+-dependent facilitation (CDF) and Ca2+-dependent inactivation (CDI) of Cav2.1 channels 
are mediated through neuronal Ca2+ sensor proteins (CaSs) like calmodulin (CaM), which binds the 
Cav2.1 subunit carboxyl terminus (Mochida et al 2008). CaM-mediated CDF and CDI are robust 
forms of Cav2.1 channel modulation in which CaM interacts with the Cav2.1 carboxyl terminus in a 
bipartite regulatory processes where CDF is mediated by a local increase in Ca2+ and CDI through a 
global increase in Ca2+ (Tsujimoto et al 2002, Chaudhuri et al 2007). Adams et al (2010) provide 
supporting evidence for the hypothesis that Ca2+ influx at Purkinje fibers boutons induces calcium-
dependent facilitation of Cav2.1 channels as a means to enhance Ca2+ influx during subsequent APs 
and achieve synaptic facilitation at the cerebellar parallel fiber (PF)-to-Purkinje cell (PC) central 
synapse. Interestingly, they demonstrated that mutations associated with human diseases affect this 
process. They observed that FHM1 gain-of-function missense mutations (R192Q and S218L) 
significantly occlude CDF of Cav2.1 currents in recombinant and native systems and that this 
alteration correlates with reduced short term synaptic facilitation at cerebellar PF-to-PC synapses. 
These findings suggest that CDF of Cav2.1 is an important mechanism required for normal synaptic 
plasticity at a fast synapse in the mammalian CNS. Additional evidence provided by two-photon 
imaging supported the fact that Cav2.1 FHM1 mutant presynaptic channels are in a constitutively 
facilitated state that basally increases presynaptic Ca2+ influx and transmitter release. Thus, observed 
changes in synaptic plasticity at the PF-to-PC synapse may result from a larger initial Ca2+ influx 
through basally facilitated mutant channels relative to unfacilitated WT channels in Purkinje fibers 
boutons. Overall, these results provide evidence that FHM1 mutations directly affect both Cav2.1 
channel CDF and synaptic plasticity and that together they likely contribute toward the 
pathophysiology underlying FHM1. The findings also suggest that Cav2.1 channel CDF is an 
important mechanism required for normal synaptic plasticity at a fast synapse in the mammalian CNS. 
 
d. Conclusions 
Calcium channels containing the  1A subunit (CaV2.1 or P/Q-type) are expressed throughout the 
human and mammalian brain with a higher concentration in the cerebellum and are localized in most 
presynaptic terminals (Catterall 1998, Wu et al. 1999, Mintz et al. 1995) as well as in the cell body and 
dendrites of many neurons (Volsen et al. 1995, Westenbroek et al. 1995). In many central synapses, 
CaV2.1 channels are preferentially located at the release sites and are more effectively coupled to 
neurotransmitter release than other Ca2+ channel types (Li et al 2007, Matsushita et al. 2002, Qian and 
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Noebels 2001, 2000, Dunlap et al. 1995, Mintz et al. 1995, Wu et al. 1999, Iwasaki et al. 2000). At 
these synapses, the action potential-evoked Ca2+ influx and the local Ca2+ increase that triggers 
neurotransmitter release are mainly determined by the kinetics of opening and closing, the open 
probability and the unitary conductance of CaV2.1 channels (Borst and Sakmann 1998, Sabatini and 
Regehr 1999, Meinrenken et al. 2002, 2003).  
In addition to the types of voltage-dependent Ca2+ channels mediating Ca2+ entry at the terminal, the 
relationship between presynaptic Ca2+ influx and neurotransmitter release is a critical aspect 
characterizing the Ca2+ induced-release of neurotransmitter. Neurotransmitter release is a power 
function of presynaptic Ca2+ current, with a power number between 3 and 4 (Dodge and Rahamimoff 
1967, Bollmann et al. 2000, Schneggenburger and Neher 2000, Mintz et al. 1995). So, even small 
changes in presynaptic Ca2+ influx have a large effect on the number of vesicles released by an action 
potential (Sabatini and Regehr 1999, Meinrenken et al. 2002). The impact of a relatively small change 
in the kinetics of activation of presynaptic Ca2+ channels on the Ca2+ current and neurotransmitter 
release evoked by an action potential at a central synapse has been shown by Borst and Sakmann 
(1998).The importance of the kinetics of activation of presynaptic Ca2+ channels in determining the 
fraction of channels that open during a short action potential and consequently, in Ca2+ current 
waveform and neurotransmitter release has been also described by Sabatini and Regehr (1999) and our 
group (González Inchauspe et al. 2010). Liu et al. (2003) have shown that different kinetics of 
inactivation and especially voltage- dependence of steady-state inactivation of Ca2+ channels have a 
striking impact on the amount and temporal pattern of Ca2+ influx in response to  repetitive firing 
waveforms. 
The specifically dominant and efficient roles of CaV2.1 channels in controlling fast neurotransmitter 
release from central excitatory synapses suggest that the human and mouse CaV2.1 channelopathies 
and their episodic neurological symptoms, ranging from migraine to absence epilepsy and ataxia, 
might be primarily synaptic diseases. These different disorders probably arise from a disruption of the 
finely tuned balance between excitation and inhibition in neuronal circuits of specific brain regions: 
the cortex in the case of migraine, the thalamus in the case of absence epilepsy and the cerebellum in 
the case of ataxia. Synapses are affected differently depending on intrinsic differences in the relative 
reliance on P/Q channels and shape of the action potential. 
The mutations in the CaV2.1 channels linked to FHM1 affect the biophysical properties and the density 
of presynaptic calcium currents as well as several other properties of synaptic transmission, like short 
term plasticity. A gain of function was observed in R192Q and S218L KI mice, that includes an 
increased Ca2+ influx through Cav2.1 channels as a consequence of mutant channels that open at lower 
voltages than WT channels (González Inchauspe et al. 2010, Tottene et al. 2002, 2005, 2009, van den 
Maagdenberg et al. 2004, 2010). Given the three-fourth power dependence of neurotransmitter release 
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on intracellular Ca2+ concentration, small changes in amplitude or time course of Ca2+ influx at the 
release sites are expected to be very effective in modulating transmitter output at those synapses where 
the Ca2+ sensors are not saturated during an action potential (Schneggenburger and Neher 2000). This 
predicts that, at such synapses, CaV2.1 channels that open more readily and at lower voltages because 
of the R192Q mutation will lead to an increased action potential-evoked Ca2+ influx and a consequent 
increase in neurotransmitter release. At the calyx of Held in P11 and older mice, transmitter release is 
triggered exclusively by P/Q-type Ca2+ channels. The hyperpolarizing shift in both the activation and 
inactivation of Cav2.1 channels had little effect on presynaptic Ca2+ currents evoked by the short 
duration APs of the same calyces. In consequence, similar EPSC amplitudes, release probability and 
pair pulse facilitation were observed in R192Q KI mice compared to WT ones. These results contrast 
with the increased release probability of the glutamatergic pyramidal cell synapses recently reported 
by Tottene et al. (2009). Nevertheless, they agree with the normal transmitter release observed at the 
fast spiking interneuron inhibitory synapses and at the neuromuscular junction studied in the same 
animal model (Kaja et al 2005, Tottene et al 2009). 
 Interestingly, R192Q KI mice did show a significant enhancement in both IpCa and EPSCs at the calyx 
of Held synapse when currents were elicited by long duration APs. These findings strongly suggest 
that synapses driven by larger amplitude and short duration APs (e.g., calyx of Held and interneurons 
APs) are less affected by the mutation-induced hyperpolarizing shift in voltage-dependence of Ca2+ 
channel activation, than those driven by longer duration APs (e.g., pyramidal neurons APs). The 
differences in AP durations that trigger cortical excitatory and inhibitory synapses might explain the 
unaltered inhibitory neurotransmission observed by Tottene et al. (2009) at the fast spiking (FS) 
interneuron-pyramidal cell (PC) synapses. It may also explain the gain of function observed at the PC-
FS interneuron excitatory synapses, since several types of interneurons and other neurons that display 
fast spiking behavior have APs with short half-widths durations (Ali et al. 2007), while PCs depicts 
long APs. Additional fctors like a faster recovery of vesicle recycling during high frequency 
transmission could also contribute to the increased excitability in FHM1 mutant mice. Although an 
established model explaining migraine attacks is still lacking, a favored hypothesis considers that the 
abnormal balance of cortical excitation-inhibition and the resulting persistent state of hyperexcitability 
of neurons in the cerebral cortex may be associated with the increased susceptibility for cortical 
spreading depression (CSD), which is believed to initiate the episodes of migraine with aura (van den 
Maagdenberg  et al 2010, Tottene et al 2009, Haerter et al. 2005, Pietrobon 2005, Lauritzen 1994, 
Welch 1998, Flippen and Welch 1997). Several results also indicate that the underlying mechanism 
changing synaptic strength by the R192Q mutation might be related to the variability in calcium 
currents according to the shape of the action potentials.  
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Genetic migraine models are useful in unraveling the triggering mechanisms for migraine attacks and 
in identifying novel migraine preventive targets and therapies. The FHM data support a key role of 
CSD in the pathogenesis of migraine aura and possibly migraine headache. It also points to cortical 
hyperexcitability as the basis for vulnerability to CSD. Cortical spreading depression seems to be a 
common mechanism underlying different forms of FHM (Moskowitz et al. 2004, Goadsby 2007). 
Mutations in the FHM1 CACNA1 gene cause increased neuronal release of neurotransmitters, more 
specifically glutamate in the cortex (Pietrobon et al. 2010) that can induce, maintain, and propagate 
CSD. On the other hand mutations in the FHM2 sodium-potassium pump gene cause reduced reuptake 
of K+ and glutamate from the synaptic cleft into the glial cell (Moskowitz et al 2004), whereas 
mutations in the FHM3 sodium channel gene result in hyperexcitabiality, excessive neuronal firing and 
most likely increased release of neurotransmitters in the synaptic cleft. The overall result is an 
increased level of glutamate and K+ in the synaptic cleft resulting in an elevated propensity for CSD 
(van den Maagdenberg et al. 2004), which supports the concept that the migrainous brain is 
hyperexcitable (Aurora and Wilkinson 2007). This fact could easily explain the aura of FHM attacks. 
More controversial, however, is whether the enhanced tendency for CSD might also be responsible for 
triggering the headache phase. Lastly, the most important question that remains to be answered is 
whether the same mechanisms also are involved in the common forms of migraine with and without 
aura.  
More than 15 years after the introduction of sumatriptan, triptans continue to be a mainstay for acute 
migraine therapy. Drugs selectively targeting the circuits now implicated in migraine, such as 
glutamate, nitric oxide, triptans, 5-hydroxytryptamine (5-Ht) 1B/1D receptor agonists (Ferrari et al 
2001) and calcitonin gene-related peptide (CGRP) receptor antagonists have demonstrated efficacy in 
both preventing (topiramate) and aborting (triptans, CGRP receptor antagonists) acute migraine 
attacks. Among these, CGRP receptor antagonists, such us olcegepant (BiBn4096Bs, Olesen et al 
2004) and telcagepant (Ho et al 2008, 2009, Williams et al 2006) may be the closest to availability for 
widespread clinical use (Ho et al 2010). Novel therapeutic strategies that consider CSD and cortical 
hyperexcitability as key targets of preventive migraine treatment promise to improve the lives of the 
large number of migraine sufferers. Notably, although drugs with migraine preventive activity belong 
to a wide range of pharmacological classes (e.g., anti-epileptics and blockers of calcium channels and 
serotinergic, beta-adrenergic, and histaminergic receptors), they all seem to share anti-CSD activity 
(Akerman & Goadsby 2005, Ayata et al. 2006). A particularly interesting compound is Tonabersat 
(SB-220453), which inhibits CSD, CSD-induced nitric oxide (NO) release and cerebral vasodilation 
(Smith et al. 2000). If proven effective, it would be the first migraine prophylactic agent developed on 
the basis of the CSD hypothesis (Goadsby et al 2009b). Other examples of potential compounds 
effective as preventive therapy for chronic migraine are Memantine, an activity-dependent N-methylD-
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aspartate receptor blocker, and Topiramate (Diener et al 2007, Silberstein et al 2007, Bussone et al. 
2005, Storer and Goadsby 2004, 2005), both inhibiting CSD (Goadsby et al 2009b, Akerman and 
Goadsby 2004). In an attempt to correlate the preventive action of a range of medications with an 
effect on CSD, Ayata et al. (2006) have studied topiramate, valproate, amitriptyline, propranolol and 
methysergide. Topiramate, valproate and amitriptyline inhibited CSD induction at doses that are 
typically used in rodent studies, none of which was similar to the dose that is used in migraine 
prevention. The dose of propranolol used was four times that reported in previous rat studies (Smits et 
al.1980), whereas methysergide had no effect on the speed of propagation (Ayata et al. 2006). CSD 
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Mutations in Cav2.1 Ca2+ channels cause familial hemiplegic migraine type 1 (FHM1). 
CaV2.1 channels with the human FHM1 mutations activate at more hyperpolarizing potentials.  
FHM1 generates a gain-of-function in synaptic transmission, affecting also synaptic plasticity.  
FHM1 increases the susceptibility for cortical spreading depression (CSD). 
 
 
 
